Informal consultation on the role of therapeutics in COVID-19 prophylaxis and post-exposure prophylaxis - 9 April 2020
9 April 2020
| Publication
Overview
Agenda items
- Global clinical evaluation of chemotherapeutics for prophylaxis
- Collective systematic assessment of the results of ongoing/soon-to-start trials on HCW (CQ/HCQ)
- Development of a global core protocol for the next studies/therapeutic agents, building on the above
- Next steps
All consultation on the role of therapeutics in COVID-19 prophylaxis and post-exposure prophylaxis
WHO Team
R&D Blue Print (RDB)
Number of pages
4